Low doses of dexamethasone constantly delivered by autologous erythrocytes slow the progression of lung disease in cystic fibrosis patients-Reference-Cited by-同舟云学术

Low doses of dexamethasone constantly delivered by autologous erythrocytes slow the progression of lung disease in cystic fibrosis patients

Published:2004-07 Issue:1 Volume:33 Page:57-63
ISSN:1079-9796
Container-title:Blood Cells, Molecules, and Diseases
language:en
Short-container-title:Blood Cells, Molecules, and Diseases

Author:

Rossi Luigia,Castro Massimo,D'Orio Francesco,Damonte Gianluca,Serafini Sonja,Bigi Leonardo,Panzani Ivo,Novelli Giuseppe,Dallapiccola Bruno,Panunzi Simona,Di Carlo Pierluigi,Bella Sergio,Magnani Mauro

Publisher

Elsevier BV

Subject

Cell Biology,Hematology,Molecular Biology,Molecular Medicine

Reference22 articles.

1. Cystic fibrosis: state of the art;Davis;Am. J. Respir. Crit. Care Med.,1996

2. Cystic Fibrosis;Konstan,1993

3. Current understanding of the inflammatory process in cystic fibrosis: onset and etiology;Konstan;Pediatr. Pulmonol.,1997

4. Corticosteroid treatment in cystic fibrosis;Price;Arch. Dis. Child.,1993

5. Risks of alternate-days prednisone in patients with cystic fibrosis;Rosenstein;Pediatrics,1991

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccine enhancement and improved immunogenicity using erythrocytes as carriers;Medical Hypotheses;2024-09

2. Drug-loaded erythrocytes: Modern approaches for advanced drug delivery for clinical use;Heliyon;2024-01

3. In situ cellular hitchhiking of nanoparticles for drug delivery;Advanced Drug Delivery Reviews;2024-01

4. Erythrocyte-based Drug Delivery: How Far from Clinical Application?;Current Drug Delivery;2024-01

5. Advances in Targeting Drug Biological Carriers for Enhancing Tumor Therapy Efficacy;Macromolecular Bioscience;2023-08